Бесплатный фондовый скринер
Load Сохранить Создать список просмотра Help180 degree capital corp. is a publicly traded registered closed-end fund focused on investing in and providing value-added assistance through constructive activism to what we believe are substantially undervalued small, publicly traded companies that have potential for significant turnarounds, i.e., a 180-degree turn. detailed information about 180 can be found on our website at www.180degreecapital.com.
- 180 Degree Capital Corp, 7 North Willow Street, Montclair 07042, United States
- 973-746-4500
- 180degreecapital.com/
- Investor relations
1ST Constitution Bancorp, through its primary subsidiary, 1STConstitution Bank, operates 26 branch banking offices in Asbury Park, Cranbury (2), Fair Haven, Fort Lee, Freehold, Hamilton, Hightstown, Hillsborough, Hopewell, Jackson, Jamesburg, Lawrenceville, Little Silver, Long Branch, Manahawkin, Neptune City, Perth Amboy, Plainsboro, Princeton, Rocky Hill, Rumson, Shrewsbury and Toms River (3), New Jersey.
- 1st Constitution Bancorp, 2650 Route 130, Cranbury 08512, United States
- 609 655 4500
- www.1stconstitution.com
- Investor relations
manufacturer of hvac equipment - rooftop units, gas heating, oem, new construction and replacement coils for industrial and commercial hvac customers. air-conditioning & warm air heating equipment & commercial & industrial refrigeration equipment manufacturing
- AAON Inc., 2425 South Yukon Avenue, Tulsa 74107, United States
- 918 583 2266
- aaon.com
- Investor relations
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
- Abeona Therapeutics Inc, 1330 Avenue of the Americas, New York 10019, United States
- 646 813 4701
- abeonatherapeutics.com/
- Investor relations
acacia research corporation (nasdaq: actg) is the industry leader in patent licensing. by partnering with patent owners, acacia applies its deep legal and technology expertise to patent assets to unlock financial value. an intermediary in the patent market, acacia facilitates efficiency and delivers monetary rewards to the patent owner. with this strategy, acacia has generated over $1,200,000,000 revenue to date, and has returned more than $705,000,000 to our patent partners.
- Acacia Research Corp, 767 3rd Avenue, New York 10017, United States
- 949 480 8300
- acaciaresearch.com/
- Investor relations
acadia is a provider of inpatient and outpatient behavioral health and addiction treatment services. acadia operates a network of 225 behavioral healthcare facilities with approximately 9,190 beds in 37 states, the united kingdom and puerto rico. acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. acadia healthcare’s behavioral health treatment facilities are specialized solely in helping children, teenagers and adults suffering from mental health disorders and/or alcohol and drug addiction.
- Acadia Healthcare Company Inc, 6100 Tower Circle, Franklin 37067, United States
- 615-861-6000
- acadiahealthcare.com/
- Investor relations
Adobe Inc., originally called Adobe Systems Incorporated, is an American multinational computer software company incorporated in Delaware and headquartered in San Jose, California.
- Adobe Inc, 345 Park Avenue, San Jose 95110-2704, United States
- 408 536 6000
- adobe.com/
- Investor relations
ADTRAN, Inc. is a provider of telecommunications networking equipment and internetworking products. Its headquarters are in Huntsville, Alabama. The company is ISO 9001 and TL9000 certified.
- ADTRAN Holdings Inc, 901 Explorer Boulevard, Huntsville 35806-2807, United States
- 256 963 8000
- adtran.com
- Investor relations
emission solutions inc is a company based out of 227 stoneybrook dr, harbor beach, mi, united states.
- Advanced Emissions Solutions Inc, 8051 E. Maplewood Avenue, Greenwood Village 80111, United States
- 720 598 3500
- ada-cs.com/home/default.aspx
- Investor relations
Advanced Micro Devices, Inc., commonly abbreviated as AMD, is an American multinational semiconductor company based in Santa Clara, California, that develops computer processors and related technologies for business and consumer markets
- Advanced Micro Devices Inc., 2485 Augustine Drive, Santa Clara 95054, United States
- 408 749 4000
- amd.com
- Investor relations